financetom
Business
financetom
/
Business
/
UK Regulator Mulls Releasing Google From Privacy Sandbox Commitments
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK Regulator Mulls Releasing Google From Privacy Sandbox Commitments
Jun 13, 2025 7:23 AM

10:04 AM EDT, 06/13/2025 (MT Newswires) -- The UK's Competition and Markets Authority or CMA has launched a consultation process on releasing Alphabet's (GOOG, GOOGL) Google ( GOOG ) from the commitments it made related to its Privacy Sandbox initiative, CMA said Friday.

The commitments were made to assure the CMA that Privacy Sandbox will not favor Google's ( GOOG ) own ad-tech services on its Chrome browser over competitors. However, Google ( GOOG ) announced in April that it no longer plans to block third-party cookies under Privacy Sandbox or ask users to do this on Chrome, the CMA said.

"The CMA believes the commitments are no longer necessary and is now consulting before it takes a decision on whether to release them later this year," the regulator said, noting that the consultation closes on July 4.

Google ( GOOG ) did not immediately respond to MT Newswires' request for comment.

Price: 175.10, Change: -1.87, Percent Change: -1.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcutis Biotherapeutics Insider Sold Shares Worth $1,517,405, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $1,517,405, According to a Recent SEC Filing
Nov 25, 2025
03:43 AM EST, 11/25/2025 (MT Newswires) -- Todd Watanabe, Director, President and Chief Executive Officer, on November 21, 2025, sold 50,000 shares in Arcutis Biotherapeutics ( ARQT ) for $1,517,405. Following the Form 4 filing with the SEC, Watanabe has control over a total of 973,671 common shares of the company, with 740,537 shares held directly and 233,134 controlled indirectly....
BridgeBio Pharma Insider Sold Shares Worth $1,722,224, According to a Recent SEC Filing
BridgeBio Pharma Insider Sold Shares Worth $1,722,224, According to a Recent SEC Filing
Nov 25, 2025
03:43 AM EST, 11/25/2025 (MT Newswires) -- Neil Kumar, Director, Chief Executive Officer, on November 20, 2025, sold 26,156 shares in BridgeBio Pharma ( BBIO ) for $1,722,224. Following the Form 4 filing with the SEC, Kumar has control over a total of 5,622,909 common shares of the company, with 228,776 shares held directly and 5,394,133 controlled indirectly. SEC Filing:...
Exelixis Insider Sold Shares Worth $3,046,928, According to a Recent SEC Filing
Exelixis Insider Sold Shares Worth $3,046,928, According to a Recent SEC Filing
Nov 25, 2025
03:40 AM EST, 11/25/2025 (MT Newswires) -- Patrick J. Haley, Executive Vice President, Commercial, on November 20, 2025, sold 72,230 shares in Exelixis ( EXEL ) for $3,046,928. Following the Form 4 filing with the SEC, Haley has control over a total of 374,029 common shares of the company, with 374,029 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/939767/000093976725000140/xslF345X05/wk-form4_1764031675.xml ...
RingCentral Insider Sold Shares Worth $2,007,427, According to a Recent SEC Filing
RingCentral Insider Sold Shares Worth $2,007,427, According to a Recent SEC Filing
Nov 25, 2025
03:42 AM EST, 11/25/2025 (MT Newswires) -- Vladimir Shmunis, Director, Chief Executive Officer and Chairman, on November 20, 2025, sold 73,862 shares in RingCentral ( RNG ) for $2,007,427. Following the Form 4 filing with the SEC, Shmunis has control over a total of 262,240 Class A common shares of the company, with 262,240 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1384905/000158664725000004/xslF345X05/form4-11252025_121133.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved